Second-Line Chemotherapy in Recurrent Glioblastoma - Still Controversial

Publisher： Karger

E-ISSN： 2296-5262|38|7-8|345-346

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.38, Iss.7-8, 2015-07, pp. : 345-346

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Second-Line Chemotherapy in Recurrent Glioblastoma: A 2-Cohort Study

By  

Oncology Research and Treatment, Vol. 38, Iss. 7-8, 2015-06 ,pp. : 348-354

Karger

Access to resources Recommend Favorite

Relevance and Necessity of Studies on Second-Line Chemotherapy in Melanoma

By  

Oncology Research and Treatment, Vol. 27, Iss. 6, 2004-12 ,pp. : 527-528

Karger

Access to resources Recommend Favorite

Second-Line Chemotherapy in Advanced Bladder Cancer

By  

Urologia Internationalis, Vol. 64, Iss. 2, 2000-05 ,pp. : 61-69

Karger

Access to resources Recommend Favorite

Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9)

By  

Oncology, Vol. 86, Iss. 5-6, 2014-06 ,pp. : 351-358

Karger

Access to resources Recommend Favorite

Relapse after localized rhabdomyosarcoma: Evaluation of the efficacy of second‐line chemotherapy

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 11, 2015-11 ,pp. : 1935-1941

John Wiley & Sons Inc

Access to resources Recommend Favorite